Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07903012Phase 3Enrolling by invitation
Phase 3, randomised trial in acne vulgaris (2 arms), sponsored by Tanta University. Primary endpoints: Number of participants with improvement at 6 months, Goodman Quantitative Global Scarring Score at 3 months and 2 more. Started Nov 2025; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07903012.